deltatrials
Terminated PHASE3 NCT00738972

Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)

Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients.

Sponsor: Fundación Lindavista del Corazón AC

Conditions Hypertension
Interventions ezetimibe (+) simvastatin pravastatin simvastatin valsartan
Updated 12 times since 2017 Last updated: Aug 17, 2013 Started: Jan 31, 2008 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This PHASE3 trial investigates Hypertension and is currently terminated or withdrawn. Fundación Lindavista del Corazón AC leads this study, which shows 12 recorded versions since 2008 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE3

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE3

▶ Show 7 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE3

  2. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE3

  3. Jun 2018 — Nov 2020 [monthly]

    Terminated PHASE3

  4. May 2018 — Jun 2018 [monthly]

    Terminated PHASE3

  5. Aug 2017 — May 2018 [monthly]

    Terminated PHASE3

  6. Feb 2017 — Aug 2017 [monthly]

    Terminated PHASE3

  7. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE3

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundación Lindavista del Corazón AC
Data source: Fundación Lindavista del Corazón AC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.